Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: Effects of Long-Term Treatment With Valaciclovir (Valtrex) on Epstein-Barr Virus

View source ↗

Summary

This completed trial evaluated the effects of long-term valacyclovir (Valtrex) treatment on Epstein-Barr virus activity. The study included participants with EB…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VALTREX (valacyclovir hydrochloride)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Epstein Barr Virus Infection, Healthy | Status: COMPLETED